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Enterovirus infections, in particular those with Coxsackieviruses, have been linked to the development of type 1 diabetes (T1D). Although
animal models have demonstrated that interferons (IFNs) regulate virus-induced T1D by acting directly on the beta cell, little is known on the
human pancreatic islet response to IFNs. Here we show that human islet cells respond to IFNs by expressing signature genes of antiviral defense.
We also demonstrate that they express three intracellular sensors for viral RNA, the toll like receptor 3 (TLR3) gene, the retinoic acid-inducible
gene I (RIG-I) and the melanoma differentiation-associated gene-5 (MDA-5), which induce type I IFN production in infected cells. Finally, we
show for the first time that the IFN-induced antiviral state provides human islets with a powerful protection from the replication of Coxsackievirus.
This may be critical for beta cell survival and protection from virus-induced T1D in humans.
© 2007 Elsevier Inc. All rights reserved.Keywords: Beta cell biology; Chemokine(s); Enterovirus; Human islets; IFN-gamma; Infection; Innate immunity type 1; IP-10; Microarray analysisIntroduction
Type 1 diabetes (T1D) is a disease that results from a
destruction of the insulin producing beta cells in the pancreatic
islets of Langerhans. Loss of beta cells leads to an inability to
regulate glucose uptake and the necessity of life-long treatment
with insulin. The disease is considered to have an autoimmune
etiology with self-reactive T cells causing beta cell destruction
(Daneman, 2006; Gillespie, 2006), and both genetic and
environmental factors, including enterovirus infections, seem
to regulate disease susceptibility (Fujinami et al., 2006; Hyoty
and Taylor, 2002; Roivainen, 2006).
Enteroviruses are a family of single-stranded, positive sense
RNA viruses (Fields, 1996; Whitton et al., 2005). Most infec-⁎ Corresponding author. Fax: +46 8 585 89681.
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doi:10.1016/j.virol.2007.05.010tions are asymptomatic or associated with only mild symptoms.
However, on rare occasions the virus is responsible for serious
disease conditions such as myocarditis and acute pancreatitis.
Epidemiological data and clinical observations have also sug-
gested a link between enterovirus infections (in particular those
with Coxsackie B viruses, CVB) and T1D (Hyoty and Taylor,
2002; Roivainen, 2006). For example, increased levels of serum
islet cell autoantibodies paralleled enterovirus infections in pre-
diabetic individuals (Hyoty et al., 1995; Moya-Suri et al., 2005),
and enteroviruses (e.g. CVBs) have on several occasions been
isolated from newly diagnosed T1D patients (e.g. Elshebani
et al., 2007; Hindersson et al., 2005; Salminen et al., 2004).
The mechanism(s) by which enterovirus infections may
contribute to beta cell destruction in humans remains to be
established (Fujinami et al., 2006; Hyoty and Taylor, 2002;
Roivainen, 2006). A suggestion has been that beta cells are
directly infected by enteroviruses and that this, at least in part,
explains the role for a viral infection in the disease process. This
hypothesis has received renewed attention due to the finding of
enterovirus RNA and protein in pancreatic islets from T1D
patients, but not healthy controls (Dotta et al., 2007; Ylipaasto
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(Flodstrom et al., 2002; Flodstrom et al., 2003; Horwitz et al.,
2001; Horwitz et al., 2002; Kanno et al., 2006). Indeed,
enterovirus infections of human pancreatic islets in vitro lead to
functional impairments and cellular damage (Chehadeh et al.,
2000; Roivainen et al., 2002).
Despite the aforementioned observations, surprisingly little
is known on the factors that regulate human islet cell
permissiveness to enterovirus infection. A mouse model for
virus-induced T1D recently demonstrated that the host critically
depends on an intact beta cell interferon (IFN) response in orderTable 1
Genes differentially expressed by human islet cells after exposure to IFNα
IFNα
Gene bank
accession no.
Gene description Ca
(IS
ds
H60298 LOC129607 Hypothetical protein LOC129607 IS
AA878880 CXCL10 (Chemokine (C–X–C motif) ligand 10) AU
T95113 Viperin Virus inhibitory protein endoplasmic
reticulum-associated, interferon inducible
IS
N63988 IFIT2 Interferon-induced protein with
tetratricopeptide repeats 2
IS
T70503 ENPP1 Ectonucleotide pyrophosphatase/
phosphodiesterase 1
IS
AA406020 G1P2, ISG15 Interferon, alpha-inducible protein
(clone IFI-15K)
IS
AA418077 GEM GTP-binding mitogen-induced
T cell protein
IS
AA489743 IFIT1 Interferon-induced protein with
tetratricopeptide repeats 1
IS
AA250771 Nameless1 IS
AA146773 2–5AS1 2′,5′-Oligoadenylate synthetase 1 IS
R01118 Nameless2 IS
N93440 C1orf38 Chromosome 1 open reading frame 38 IS
R72244 2–5AS2 2′–5′-Oligoadenylate synthetase 2 IS
AA781508 FLJ38348 Coiled-coil domain containing 75 IS
AA406571 CEACAM1 Carcinoembryonic antigen-related cell
adhesion molecule 1
IS
AA491191 IFI16 Interferon, gamma-inducible protein 16 IS
AA459898 FLJ22471 Coiled-coil domain containing 92 IS
AA447482 SP100 SP100 nuclear antigen IS
AA478959 ADPRTL1 Poly (ADP-ribose) polymerase family,
member 4
IS
AA419251 IFITM1 Interferon induced transmembrane
protein 1
IS
AA074511 SDC1 Syndecan 1 IS
AA432030 G1P3, IFI6 Interferon, alpha-inducible protein 6 ds
W24246 IFIT5 Interferon-induced protein with
tetratricopeptide repeats 5
AU
The table lists genes that were up-regulated≥1.5-fold in islets exposed to IFNα from
preparations analyzed, and the genes were listed according to the level of induction.
Reference Database (www.hprd.org). ISG: IFN stimulated gene; AU: gene contain
indicates genes known to contribute to the host antiviral defense by extracellular meto survive a systemic CVB infection without suffering from beta
cell loss and the development of T1D (Flodstrom et al., 2002;
Flodstrom et al., 2003; Flodstrom-Tullberg et al., 2005). These
studies demonstrated an important role for IFNs in regulating
murine beta cell permissiveness to CVB infection in vitro and in
vivo. They also showed that murine islets respond to IFNs by
upregulating the expression of genes involved in antiviral
defense, thereby protecting them from CVB replication
(Flodstrom-Tullberg et al., 2005).
It is unknown whether IFNs induce antiviral defense path-
ways in human islets and if IFNs protect human islets fromtegory
G/AU/
RNA)
Fold induction
Mean (range)
Biological
process
Demonstrated
or proposed
antiviral activity
G 8.2 (5.2–11.4) Unknown
7.9 (5.4–10.1)a Immune response (+)
G 7.0 (5.4–10.1)a Immune response +
G 6.9 (6.4–7.5)a Unknown
G 5.8 (3.6–10.9) Metabolism,
energy pathways
G 5.2 (3.9–6.9)a Immune response +
G 3.9 (3.0–4.6)a Signal transduction,
cell communication
G 3.8 (2.6–4.7)a Protein metabolism
G 3.7 (3.3–4.4)a Unknown
G 3.0 (2.5–3.9) Immune response +
G 2.8 (1.7–3.8) Unknown
G 2.7 (2.0–3.6) Signal transduction,
cell communication
G 2.5 (2.0–3.4) Immune response +
G 2.5 (1.7–3.2) Regulation of nucleobase,
nucleoside, nucleotide and
nucleic acid metabolism
G 2.4 (1.6–3.4) Immune response
G 2.4 (1.9–3.1) Regulation of nucleobase,
nucleoside, nucleotide and
nucleic acid metabolism
G 2.3 (1.6–3.1) Unknown
G 2.2 (1.8–3.8) Regulation of nucleobase,
nucleoside, nucleotide and
nucleic acid metabolism
G 2.0 (1.7–2.3) Regulation of nucleobase,
nucleoside, nucleotide and
nucleic acid metabolism
G 1.9 (1.7–2.3) Signal transduction,
cell communication
+
G 1.8 (1.6–2.0) Signal transduction,
cell communication
RNA 1.7 (1.5–1.9) Immune response
1.7 (1.5–2.0)a Unknown
all four donors. Data is presented as the mean fold induction among the four islet
Each gene was assigned to a biological process, according to the Human Protein
ing adenylate/uridylate-rich elements; dsRNA: gene inducible by dsRNA; (+)
chanisms; a, mean value of n≥2 probes.
94 M. Hultcrantz et al. / Virology 367 (2007) 92–101enterovirus replication. The human islet cell response to the
damaging cytokine combination IFNγ+IL1β, and the islet
response to IFNγ, with regards to autoimmune mediated in-
flammation, have recently been described (Sarkar et al., 2007;
Ylipaasto et al., 2005). However, no previous efforts have been
made to characterize the antiviral response to type I IFN (e.g.
IFNα) or type II IFN (IFNγ) alone.
Here we studied the expression of antiviral defense genes in
human islets exposed to IFNs. We also evaluated human islet
permissiveness to CVB replication after IFN treatment. Using a
custom innate immune response array, real-time (RT) PCR and
Western blot (WB) analysis we show that human islets exposed
to IFNs express several genes associated with antiviral defense
and inflammation. Furthermore, we demonstrate that IFN-
stimulated human islets express three sensors for viral RNA,
namely the toll like receptor 3 (TLR3) gene, the retinoic acid-
inducible gene I (RIG-I) and the melanoma differentiation-
associated gene-5 (MDA-5, also referred to as IFIH1 or
Helicard). Finally, we show that IFN treatment strongly
suppresses the replication of CVB3 in human islets. Taken
together, our results demonstrate that IFNs induce human islet
antiviral defense. They also indicate that by responding to IFNs
human islets regulate their intrinsic ability to detect an infecting
virus and to affect intra-islet inflammation.
Results
IFNs upregulate the expression of genes known to be involved
in antiviral defense and lymphocyte chemotaxis
To study the human islet antiviral response to IFNs, human
islet preparations from four separate donors were subjected to a
6-h stimulation with IFNα or IFNγ. Isolated RNA was
analyzed using a custom cDNA microarray holding probes
for 2178 genes involved in innate immune responses (see
Materials and methods; Malathi et al., 2005). IFN stimulation
induced the expression of multiple genes (Tables 1 and 2, and
Supplementary Table 1). Compared to control islets, a total ofTable 2
Genes differentially expressed by human islet cells after exposure to IFNγ
IFNγ
Gene bank
accession no.
Gene
description
AA878880 CXCL10 Chemokine (C–X–C motif) ligand 10
N63988 IFIT2 Interferon-induced protein with
tetratricopeptide repeats 2
AA664040 WARS Tryptophanyl-tRNA synthetase
T95113 Viperin Virus inhibitory protein endoplasmic
reticulum-associated, interferon inducible
H60298 LOC129607 Hypothetical protein LOC129607
AA489743 IFIT1 Interferon-induced protein with
tetratricopeptide repeats 1
The table lists genes that were up-regulated≥1.5-fold in islets exposed to IFNγ from
preparations analyzed, and the genes were listed according to the level of induction.
Reference Database (www.hprd.org). ISG: IFN stimulated gene; AU: gene conta
(+) indicates genes known to contribute to the host antiviral defense by extracellula23 and 6 genes demonstrated a ≥1.5-fold increased expression
in all islet preparations (4/4) treated with IFNα or IFNγ,
respectively (all genes, including those that were altered in
some, but not all, donors are presented in Supplementary Table
1). None of the genes included in the array were consistently
down-regulated in islets from all four donors. Among the
induced genes with a known function, a significant number
have previously been associated with intracellular antiviral
activity; IFNα induced the expression of Viperin (virus inhi-
bitory protein endoplasmic reticulum-associated, interferon
inducible) (Chin and Cresswell, 2001; Helbig et al., 2005),
ISG15 (Lenschow et al., 2007), 2–5AS1 (2–5 oligoadenylate
synthetase 1), 2–5AS2 (Justesen et al., 2000) and IFITM1
(Constantoulakis et al., 1993) (Table 1), and IFNγ induced the
expression of Viperin (Table 2).
IFNα is a potent inducer of genes encoding antiviral proteins
and CXCL10
We next used RT-PCR analysis to study the expression of
genes selected based upon the results from the microarray
analysis. The expression of mRNA encoding Viperin, a protein
with antiviral activity (Chin and Cresswell, 2001; Helbig et al.,
2005), was strongly induced in human islets after stimulation
with IFNα (Fig. 1A) (pb0.01 vs. control), and to a certain
extent in islets from all four donors also by IFNγ (not
significant). Similarly, IFNs induced the expression of 2–
5AS2, one of the rate limiting enzymes in the antiviral 2–5AS/
RNaseL pathway (Justesen et al., 2000). As shown in Fig. 1B,
exposure to IFNα led to a robust expression of 2–5AS2 mRNA
(pb0.01, vs. control), while the induction induced by IFNγ
failed to reach statistical significance. The chemokine CXCL10
recruits activated T cells to inflammatory sites and is expressed
by parenchymal cells during infection and inflammation
(Christen and Von Herrath, 2004, and references therein). We
found that CXCL10 mRNA was upregulated in human islets
following exposure to both IFNα and IFNγ (pb0.05, vs.
control, Fig. 1C).Category
(ISG/AU/
dsRNA)
Fold induction
Mean (range)
Biological
process
Demonstrated
or proposed
antiviral activity
AU 8.2 (6.4–10.0)a Immune response (+)
ISG 3.5 (1.8–5.5)a Unknown
ISG 3.5 (2.3–4.5) Protein metabolism
ISG 2.6 (1.9–3.6)a Immune response +
ISG 2.3 (1.9–3.4) Unknown
dsRNA 1.9 (1.7–2.0)a Protein metabolism
all four donors. Data is presented as the mean fold induction among the four islet
Each gene was assigned to a biological process, according to the Human Protein
ining adenylate/uridylate-rich elements; dsRNA: gene inducible by dsRNA;
r mechanisms; a, mean value of n≥2 probes.
Fig. 2. Genes involved in the recognition of intracellular viral RNA are
expressed by IFN-treated human islets. cDNA isolated from human islets treated
for 6 h with IFNα or IFNγ (n=4) was analyzed by RT-PCR analysis. The
expression levels of RIG-I (A), MDA-5 (B) and TLR3 (C) were normalized
against GAPDH and shown as fold induction compared to untreated controls.
⁎⁎pb0.01 vs. untreated controls, Kruskal–Wallis test.
Fig. 1. IFNs regulate the expression of antiviral defense genes in human islets.
RT-PCR analysis of cDNA isolated from human islets (n=4) treated for 6 h with
IFNα or IFNγ. The expression levels of Viperin (A), 2–5AS2 (B) and CXCL10
(C) were normalized against GAPDH and shown as fold induction compared to
untreated controls. ⁎pb0.05, ⁎⁎pb0.01 vs. untreated controls, Kruskal–Wallis
test.
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detection
Todd and colleagues recently identified a new T1D
susceptibility locus (Smyth et al., 2006). A candidate within
this locus is the gene encoding the cytosolic viral RNA sensor
MDA-5 (also denoted IFIH1, or Helicard). Although this gene
is induced by IFNs in some cell types (Kang et al., 2004), it was
not included in the presently used array. As it remains unknown
whether this is an IFN-inducible gene in human islets, we next
determined its expression in control and IFN-treated islets. In
parallel, we studied the expression of two other known
intracellular sensors for viral RNA, namely RIG-I and TLR3.
RIG-I recognizes 5′triphosphate RNA present in many RNA
viruses (Hornung et al., 2006; Pichlmair et al., 2006), and acts
via the same signaling pathway as MDA-5 to induce type I IFN
production in virus-infected cells (Gitlin et al., 2006; Kato et al.,2006). TLR3 located in the endosomes induces type I IFN
after detection of phagocytosed double stranded (ds)RNA
(Alexopoulou et al., 2001).
Interestingly, mRNA for all three genes were expressed in
human islets (Fig. 2) and their expression levels increased
significantly following IFNα-treatment. We also observed a
small, yet non-significant, increase in the expression of the three
genes after exposure to IFNγ, indicating that type I IFNs are
more potent inducers of these genes in human islets.
Islets express proteins involved in viral recognition and defense
To analyze whether increased mRNA expression translated
into increased protein levels, we studied the protein expression
of three selected genes, namely Viperin, MDA-5 and RIG-I in
human islets treated with IFNα or IFNγ for 6 or 24 h. The WB
analysis revealed no Viperin expression in untreated control
islets. However, a strong band appeared after 6-h treatment with
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24 h of exposure (Fig. 3A). Analogous to the mRNA expression
analysis IFNγ did not induce a notable expression of this
protein. The protein expression patterns of MDA-5 and RIG-I
were also similar to those observed on the mRNA levels: IFNα
treated islets expressed significantly higher levels of both
proteins as compared to untreated control islets (Figs. 3B and
C). The increased expression was observed already after 6 h and
was still increased after 24 h of treatment. Moreover, only non-
significant increases in MDA-5 and RIG-I expression levels
were observed following IFNγ exposure.
IFNs protect human islets from CVB3 replication
The results above demonstrated that IFNs induce the
expression of several genes known to be involved in
intracellular antiviral defense. Therefore, the next question we
addressed was whether IFNs induce an antiviral state in human
islet cells. Human islet cells are permissive to CVBs (Ylipaasto
et al., 2004; Yoon et al., 1979), however it has not been shown
whether IFNs regulate their permissiveness to CVB infection.
To determine this, human islets were treated with IFNs for 24 h
and then infected with CVB serotype 3 (Nancy) followed by
culture under continuous exposure to IFNs. Virus titers were
measured in the culture media on day 2, 4 and 6 post infection
(p.i.). As previously shown, CVB3 replicated in cultured human
islets (Chehadeh et al., 2000; Roivainen et al., 2002) (Fig. 4).
Interestingly, we found a considerable block in CVB3Fig. 3. Human pancreatic islets express proteins involved in viral recognition and defe
or 24 h (n=6) were analyzed by WB analysis. To the left, representative blots for Vip
and RIG-I (C) bands (24 h) were normalized against the density of the bands for act
Viperin expression in untreated control islets precluded such analysis for Viperin ex
test.replication in islets treated with IFNs (Fig. 4A); IFNα led to a
nearly complete protection from CVB replication, as shown by
the presence of a 1000-fold lower virus titers in media from
IFNα-treated islets compared to titers in media from untreated
islets. On day 6 p.i. the viral titers from IFNα treated islets were
near the detection limit of the assay. IFNγ also prevented CVB3
replication, although less dramatically (Fig. 4A). Parallel
experiments showed that a 24-h pre-treatment period with
IFNs was sufficient to provide a robust protection from CVB3
replication. On day 2 p.i. virus titers were similar in media from
islets cultured in the presence or absence of IFNα and IFNγ
after infection. However, continuous treatment with IFNs was
required for a sustained protection (Fig. 4B).
Discussion
The present study shows for the first time that human
pancreatic islet cells respond to type I (IFNα) and to a certain
extent also type II (IFNγ) IFNs by upregulating the expression
of several genes involved in antiviral defense and viral
detection. Moreover, it demonstrates that human islets enter
an antiviral state after exposure to IFNs, which strongly reduces
their permissiveness to CVB3 infection.
A number of genes known to be involved in antiviral defense,
such as Viperin, 2–5AS and CXCL10, were identified among
the IFN-inducible genes in human islets (Tables 1 and 2, Fig. 1).
Viperin has an antiviral effect against human cytomegalovirus
and hepatitis C virus in vitro (Chin and Cresswell, 2001; Helbignse. Protein extracts from human islets treated with IFNα or IFNγ for 6 h (n=2)
erin (A), MDA-5 (B) and RIG-I (C). To the right, the density of the MDA-5 (B)
in and shown as fold induction compared to untreated controls. The absence of
pression levels. ⁎⁎pb0.01, ⁎⁎⁎pb0.001 vs. untreated controls, Kruskal–Wallis
Fig. 4. IFNs protect human islets from CVB replication. Human islets from six
donors were treated with IFNs (IFNα or IFNγ) for 24 h, infected with CVB3,
and cultured in the presence of IFNs (A). In two experiments some islets only
received IFNs during the 24 h pre-treatment period (B, one representative
experiment out of two is shown), as described in Materials and methods. Media
was changed every 48 h p.i., and titers of replicating virus in the harvested media
was measured using a standard plaque assay technique. ⁎pb0.05 ⁎⁎pb0.01,
⁎⁎⁎pb0.001 vs. untreated controls, two-way RM ANOVA.
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treatment and during infection with both RNA and DNAviruses
(Chin and Cresswell, 2001; Helbig et al., 2005). It is also
expressed in human islets following in vitro infection with CVB,
and after stimulation with IL-1+ IFNγ (Ylipaasto et al., 2005).
Here we demonstrate that Viperin mRNA and protein are
expressed by human islets following either IFNα or IFNγ
stimulation alone, and follow up studies will demonstrate
whether Viperin contributes to human islet anti-CVB defense.
Upon encounter of dsRNA, the enzymes 2–5ASs synthesize
2–5 oligoadenylates (2–5As), which in turn activate the
intracellular endonuclease RNaseL. The 2–5ASs are IFN-
regulated genes and their level of expression is often the rate-
limiting step in the 2–5AS/RNaseL pathway (Justesen et al.,
2000). This pathway is important for protection from various
viruses, including CVB (Flodstrom-Tullberg et al., 2005; Zhou
et al., 1997), and we have previously shown that it contributes to
the IFNα-mediated protection of mouse islets from destruction
by CVB in vitro (Flodstrom-Tullberg et al., 2005). The presentstudy demonstrates that the 2–5ASs are IFN-regulated genes
also in human islet cells.
CXCL10 is a chemokine that attracts CXCR3 expressing T
cells to sites of infection and inflammation (Christen and Von
Herrath, 2004, and references therein). Others have shown
that human islets express CXCL10 following treatment with
IFNγ in combination with other cytokines, or after CVB
infection (Berg et al., 2006; Cardozo et al., 2003; Ylipaasto et
al., 2005). The present study shows that CXCL10 mRNA
expression is significantly increased following IFNα treatment
alone (Tables 1 and 2, Fig. 1C). Studies in an animal model
have shown that islet production of CXCL10 during infection
leads to a recruitment of virus-specific CXCR3+ T cells to the
islets (Rhode et al., 2005), suggesting that IFN-induced
human islet expression of CXCL10 is central in the host
defense against viruses with a tropism for pancreatic islet
cells. Of note, CXCL10 expression may also recruit islet-
reactive T cells to the pancreas in individuals predisposed
to develop T1D (Frigerio et al., 2002; Rhode et al.,
2005).
Type I IFNs are produced early following virus infection,
including infections with members of the picornaviridae
family, such as the enteroviruses (Flodstrom-Tullberg, 2003;
Nakayama et al., 1989; Pozzetto and Gresser, 1985; Yoon et
al., 1980). Cells at the local site of infection (gastrointestinal
mucosa for enteroviruses) (Fields, 1996; Whitton et al.,
2005), including dendritic cells, are likely to respond rapidly
to infection by producing IFNα and/or IFNβ. The type I
IFNs, acting locally and systemically, contribute to the
antiviral response by inducing an antiviral state in uninfected
cells, and by triggering apoptosis in already infected cells
(Garcia-Sastre and Biron, 2006). The present study demon-
strates that IFNs provide human islets with a robust protection
from CVB replication (Fig. 4), suggesting that the IFN
response may have a similar role as in mouse islet cells to
determine permissiveness to CVB infection in vivo (Flod-
strom et al., 2002; Flodstrom et al., 2003). IFNα afforded a
robust protection from CVB replication, while IFNγ was
somewhat less powerful. This may reflect the observation that
IFNγ was not as potent as IFNα in up-regulating the
expression of antiviral defense genes (Figs. 1 and 3).
Moreover, it shows that type I IFNs may be more important
than IFNγ in regulating human islet permissiveness to this
particular enterovirus.
Chehadeh et al. (2000) have previously shown that human
islets produce type I IFN in response to CVB infection in vitro.
An interesting observation in the present study was that IFN-
stimulated human islets upregulate the expression of genes
known to promote the production of type I IFNs during virus
infection. The mRNA expression levels for TLR3 and two
cytoplasmic helicase proteins involved in viral RNA recogni-
tion, MDA-5 and RIG-I, as well as the protein levels of MDA-5
and RIG-I, were increased following IFNα exposure. Upon
recognition of intracellular viral RNA TLR3, located in
endosomes, and MDA-5 and RIG-I, located in the cytosol,
induce type I IFN production via the activation of IRF-3 and
IRF-7. Recent findings suggest that MDA-5 and RIG-I have
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recognizing different RNA viruses: MDA-5 recognizes picor-
naviruses, such as encephalomyocarditis virus (EMCV), while
RIG-I detects RNA viruses with a 5′triphosphate end including
paramyxovirus, influenza virus and Japanese encephalitis virus
(Gitlin et al., 2006; Hornung et al., 2006; Kato et al., 2006;
Pichlmair et al., 2006). A previous microarray analysis
indicated that MDA-5 and RIG-I mRNAs are expressed by
human islets during in vitro CVB infection or after exposure to
IL-1β+IFNγ (Ylipaasto et al., 2005), however no attempts
were made in this study to further verify the expression of these
genes. Moreover, whether MDA-5 and RIG-I are expressed in
human islets after exposure to IFNs alone had previously not
been evaluated. In the present study RT-PCR analysis showed
that mRNA for MDA-5, RIG-I and TLR3 are expressed in
human islets, and that the expression is increased following
IFN exposure, particularly after exposure to IFNα. Based upon
these observations, and the study by Chehadeh et al. (2000), it
is tempting to speculate that human islet cells could contribute
to the regulation of their own permissiveness to certain virus
infections by TLR3, MDA-5- or RIG-I-induced endogenous
type I IFN production. Considering the clinical and epidemio-
logical associations between enterovirus infections and T1D
(Fujinami et al., 2006; Hyoty and Taylor, 2002; Roivainen,
2006), the human islet expression of MDA-5 mRNA is of
particular interest. This gene was recently identified as a strong
candidate gene within a new T1D susceptibility locus (Smyth
et al., 2006).
A final noteworthy observation was that although an IFN-
induced increase in mRNA expression levels observed in the
microarray analysis matched with an increased mRNA expres-
sion level of selected genes in the RT-PCR analysis, the latter
analysis demonstrated higher increases in IFN-induced mRNA
expression levels than the microarray analysis did (compare
Tables 1 and 2 with Figs. 1 and 2). It is therefore possible that a
lower sensitivity in the microarray analysis may have lead to an
underestimation of the number of genes regulated by IFNs in
human islets. Indeed, a recent study by Cardozo et al.
demonstrated that IFNγ increases human islet mRNA expres-
sion of IL-15, a growth and activation factor for T cells and NK
cells (Cardozo et al., 2003). The present microarray analysis
showed a ≥1.5-fold induction of IL-15 mRNA in three out of
four islet preparations stimulated with IFNγ (average fold
induction 2.2, range 1.3–3.3, Supplementary Table 1). As a
strict criteria for the selection of the genes presented in Tables 1
and 2 was applied, namely that the change in expression
between IFN-stimulated and control islets should be ≥1.5-fold
in islets from all four donors, IL-15 was not included in the
tables and its expression not further evaluated. Similarly, a
number of other genes (e.g. IRF1) demonstrated an up-regulated
expression in only some but not all donors. Therefore a
complete list of all genes included in the array, as well as
data from each donor and treatment, has been included in
Supplementary Table 1.
In conclusion, this study supports a notion that human islet
cells, by responding to IFNs, regulate islet infection and
inflammation (Hill et al., 2007). It demonstrates that IFNsinduce the expression of genes involved in antiviral defense,
and provide a robust protection from CVB replication. It also
shows that human islets express genes involved in intracellular
detection of viral RNA. These genes are known to induce type I
IFN production (Gitlin et al., 2006; Kato et al., 2006),
suggesting that islet cells have the capacity to produce type I
IFNs during infection (e.g. CVB; Chehadeh et al., 2000) and
thereby contribute to the local, intracellular antiviral response.
Several observations suggest that IFNs, including an altered
IFN production, contribute to the development of T1D in
humans (Corbett et al., 1993; Foulis, 1996; Mandrup-Poulsen et
al., 1985; Rhodes and Taylor, 1984; Skarsvik et al., 2006). By
providing a basic understanding for how human beta cells
respond to IFNs and how this relates to their defense against a
pancreatropic virus associated with the development of T1D,
this study may contribute to a future unraveling of the
mechanisms underlying beta cell loss in T1D.
Materials and methods
Human islets
Human islets from 10 donors (five female and fivemale) were
purified from human cadaver donors at the Uppsala University
Hospital, as a part of The Nordic Network for Clinical Islet
Transplantation, as previously described (Goto et al., 2004). The
average donor age was 57±12 years (range 36 to 74 years), and
the cold ischaemia time was 8.24±4.35 h (range 4.34 to
20.04 h). The islets had a purity of 83±12% (range 60–95%), as
determined by dithizone staining, and were further purified by
hand picking. The quality of the islets was evaluated by
insulin release in response to higher glucose concentrations.
For eight donors a dynamic perfusion system was used as
previously described (Johansson et al., 2003). The islets
responded with a stimulation index of 14.5±10.7 (range 3.6
to 32.3). For two donors glucose-stimulated insulin release
was measured after static incubation and the simulation
index for these islets were 3.2 and 3.8 respectively.
The IFN stimulations of islets for the microarray analysis
were performed at the Uppsala University Hospital, Uppsala,
while all other experiments were conducted at Karolinska
Institutet (KI), Stockholm. On days 2–4 after isolation the islets
were shipped on wet-ice to KI (approximate time on ice was
≤3 h) and the experiments were performed after a 2-day
recovery. Upon isolation the islets were cultured in CMRL-
1066 supplemented with 10 mM Nicotinamide, 10 mM HEPES
buffer, 0.25 μg/ml fungizone, 50 μg/ml gentamycin, 2 mM L-
glutamine, 10 μg/ml ciprofloxacin and 10% heat-inactivated
human serum. After arrival at KI the islets were transferred to
RPMI-1640 with the same supplements as above but with fetal
calf serum (FCS) instead of human serum and without
Nicotinamide. The islets were exposed for 6 or 24 h to
IFNα2b (1000 U/ml; Intron®A, Schering-Plough) or IFNγ1b
(1000 U/ml; Imukin®, Boehringer Ingelheim). The experiments
were approved by local ethics committees in Uppsala and
Stockholm and performed in accordance with the principles of
the Declaration of Helsinki 2000.
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Total RNA from human pancreatic islets was isolated using
an RNeasy® kit (Qiagen, UK). The quantity and quality of the
RNAwas determined using an Agilent Bioanalyzer (performed
by the Bio-informatics and Expression Analysis core facility at
KI). RNA from four donors was converted into cDNA and
analyzed on a microarray, described in (Malathi et al., 2005),
representing 2178 genes involved in innate immune responses
(consisting of 950 genes containing adenylate/uridylate (AU)-
rich elements, 855 interferon stimulated genes (ISGs), 288
dsRNA responsive genes and 85 housekeeping genes). Genes
that demonstrated a change in expression of 1.5 fold or more in
islets from all four donors after IFNα or IFNγ treatment were
functionally categorized according to the Human Protein
Reference Database (www.hprd.org) and presented in Tables
1 and 2. cDNA was synthesized using SuperScript™ First-
Strand Synthesis System for RT-PCR (Invitrogen, Sweden).
Real-Time PCRs for 2–5AS2, CXCL10 and GAPDH were run
with TaqMan® Gene Expression assays (Applied Biosystems,
Sweden). Real-time PCR for Viperin, RIG-I, MDA-5 and
GAPDH was run with RT2 Real-Time™ SYBR Green/ROX
PCR master mix (SuperArray, Sweden). The primers for
Viperin (Olofsson et al., 2005) were custom made by
Invitrogen, and for RIG-I, MDA-5 and GAPDH QuantiTect®
Primer Assays (Qiagen) were used. The mRNA expression
level for each gene was normalized against mRNA for the
housekeeping gene GAPDH.
Western blot analysis
Islet cells were lysed in RIPA buffer (20 nM Tris pH 7.5,
1 mM EDTA, 140 mM NaCl, 1% NP40, 1 mM Phenyl-
methylsulfonyl fluoride, 1 μg/ml Aprotinin and 1 mM
activated Na3VO4) and homogenized using a tissue homo-
genizer. After centrifugation the supernatants were collected
and the total protein concentrations determined using a BCA
Protein Assay Kit (Pierce, Sweden). Equal amounts of total
protein extracts from each sample were loaded together with
Laemmli Sample Buffer with 5% β-mercaptoethanol (Bio-
Rad, Sweden) on SDS polyacrylamide gels (7.5% for MDA-5
and RIG-I or 12% for Viperin), electrophoresed and
transferred to nitrocellulose membranes (Bio-Rad, Sweden).
The membranes were incubated over night with antibodies to
MDA-5 or RIG-I diluted 1:1000 (Alexis Biochemicals,
Switzerland) or antibodies to Viperin diluted 1:2000 (a gift
from Dr. Cresswell, Yale University School of Medicine, New
Haven, USA). Binding of primary antibody was detected
using anti-rabbit or anti-mouse HRP conjugated antibodies
(Bio-Rad, Sweden) diluted 1:1000 for 1 h at room
temperature and visualized by SuperSignal® West Dura
Extended Duration Substrate (Pierce, Sweden). Images were
captured by a Flour Chem SP (Alpha Innotech). To guarantee
equal loading, membranes were stripped with 8 mg/ml NaOH
for 5 min and relabeled with antibodies against actin, diluted
1:30.000 (MP Biomedicals, Aurora, Ohio, USA) followed by
detection as described above. Band densities for the differentproteins were analyzed by NIH Image 1.63 and normalized
against actin.
Virus stock and infection
A stock of CVB3 Nancy, obtained fromDr. G. Frisk, Uppsala
University, was prepared and the titer determined as described
(Horwitz et al., 1998). In vitro infections were performed as
previously described (Flodstrom et al., 2002). Briefly, islets were
treated for 24 hwith IFNα or IFNγ (1000 U/ml) or left untreated.
Islets (n=40) from each condition were washed with serum free
media and infected for 1.5 h with 1.2×106 PFU/ml in 2ml serum
free media. Thereafter, the islets were washed three times and
placed in Millicell culture plate inserts (Millipore) containing
1 ml of fresh culture medium, with or without IFNs (IFNα
1000 U/ml or IFNγ 1000 U/ml). The islets were incubated at
37°C and the media was changed, and islets washed, every
second day until day 6 post infection (p.i.). After each media
change, fresh IFNs were added (IFNα 1000 U/ml, or IFNγ
1000 U/ml) except in the experiments presented in Fig. 4B
where, as indicated, fresh IFNs were added only to some islets.
Viral titers of the culture media were determined by a standard
plaque assay using HeLa cells (Horwitz et al., 1998). Potential
virus left in the last wash media after infection was below
detection limit of the assay. Viral titers were quantified as PFU/
ml and presented as log10 PFU/ml. The lower detection limit of
the assay was 25 PFU/ml islet culture medium.
Statistics
Statistical analyses were performed using GraphPad Prism
version 4 software. RT-PCR and WB data were analyzed using
Kruskal–Wallis test (non-parametric ANOVA) and compari-
sons of viral titers were analyzed by two-way repeated
measurements (RM) ANOVA. Data are represented as the
mean±S.D.
Acknowledgments
The authors thank the Nordic Network for Clinical Islet
Transplantation for providing the human islets. We also
gratefully acknowledge Dr. P.W. Faber and the Genomics Core
at the Lerner Institute, Cleveland, Ohio, for excellent technical
assistance and analyses of the microarray data, Dr. P. Cresswell
at the Yale University School of Medicine, New Haven, for the
antibody against Viperin, and Drs. G. Frisk and M. Wareing for
discussions and critical reading of the manuscript. These studies
were supported by a Marie Curie International Reintegration
grant, the Juvenile Diabetes Research Foundation, the European
Foundation for the Study of Diabetes, the Swedish Foundation
for Strategic Research, the Swedish Research Council and the
Åke Wiberg and Jeansson's Foundations.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.virol.2007.05.010.
100 M. Hultcrantz et al. / Virology 367 (2007) 92–101References
Alexopoulou, L., Holt, A.C., Medzhitov, R., Flavell, R.A., 2001. Recognition of
double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.
Nature 413 (6857), 732–738.
Berg, A.K., Korsgren, O., Frisk, G., 2006. Induction of the chemokine
interferon-gamma-inducible protein-10 in human pancreatic islets during
enterovirus infection. Diabetologia 49 (11), 2697–2703.
Cardozo, A.K., Proost, P., Gysemans, C., Chen, M.C., Mathieu, C., Eizirik,
D.L., 2003. IL-1beta and IFN-gamma induce the expression of diverse
chemokines and IL-15 in human and rat pancreatic islet cells, and in islets
from pre-diabetic NOD mice. Diabetologia 46 (2), 255–266.
Chehadeh, W., Kerr-Conte, J., Pattou, F., Alm, G., Lefebvre, J., Wattre, P.,
Hober, D., 2000. Persistent infection of human pancreatic islets by
coxsackievirus B is associated with alpha interferon synthesis in beta
cells. J. Virol. 74 (21), 10153–10164.
Chin, K.C., Cresswell, P., 2001. Viperin (cig5), an IFN-inducible antiviral
protein directly induced by human cytomegalovirus. Proc. Natl. Acad. Sci.
U. S. A. 98 (26), 15125–15130.
Christen, U., Von Herrath, M.G., 2004. IP-10 and type 1 diabetes: a question of
time and location. Autoimmunity 37 (5), 273–282.
Constantoulakis, P., Campbell, M., Felber, B.K., Nasioulas, G., Afonina, E.,
Pavlakis, G.N., 1993. Inhibition of Rev-mediated HIV-1 expression by an
RNA binding protein encoded by the interferon-inducible 9–27 gene.
Science 259 (5099), 1314–1318.
Corbett, J.A., Sweetland, M.A., Wang, J.L., Lancaster Jr., J.R., McDaniel, M.L.,
1993. Nitric oxide mediates cytokine-induced inhibition of insulin secretion
by human islets of Langerhans. Proc. Natl. Acad. Sci. U.S.A. 90 (5),
1731–1735.
Daneman, D., 2006. Type 1 diabetes. Lancet 367 (9513), 847–858.
Dotta, F., Censini, S., van Halteren, A.G., Marselli, L., Masini, M., Dionisi, S.,
Mosca, F., Boggi, U., Muda, A.O., Prato, S.D., Elliott, J.F., Covacci, A.,
Rappuoli, R., Roep, B.O., Marchetti, P., 2007. Coxsackie B4 virus infection
of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic
patients. Proc. Natl. Acad. Sci. U.S.A. 104 (12), 5115–5120.
Elshebani, A., Olsson, A., Westman, J., Tuvemo, T., Korsgren, O., Frisk, G.,
2007. Effects on isolated human pancreatic islet cells after infection with
strains of enterovirus isolated at clinical presentation of type 1 diabetes.
Virus Res. 124 (1–2), 193–203.
Fields, B.N., 1996. Fields Virology, 3rd ed. Raven Press, New York, NY.
Flodstrom, M., Maday, A., Balakrishna, D., Cleary, M.M., Yoshimura, A.,
Sarvetnick, N., 2002. Target cell defense prevents the development of
diabetes after viral infection. Nat. Immunol. 3 (4), 373–382.
Flodstrom, M., Tsai, D., Fine, C., Maday, A., Sarvetnick, N., 2003.
Diabetogenic potential of human pathogens uncovered in experimentally
permissive beta-cells. Diabetes 52 (8), 2025–2034.
Flodstrom-Tullberg, M., 2003. Viral infections: their elusive role in regulating
susceptibility to autoimmune disease. Microbes Infect. 5 (10), 911–921.
Flodstrom-Tullberg, M., Hultcrantz, M., Stotland, A., Maday, A., Tsai, D., Fine,
C., Williams, B., Silverman, R., Sarvetnick, N., 2005. RNase L and double-
stranded RNA-dependent protein kinase exert complementary roles in islet
cell defense during coxsackievirus infection. J. Immunol. 174 (3),
1171–1177.
Foulis, A.K., 1996. The pathology of the endocrine pancreas in type 1 (insulin-
dependent) diabetes mellitus. APMIS 104 (3), 161–167.
Frigerio, S., Junt, T., Lu, B., Gerard, C., Zumsteg, U., Hollander, G.A., Piali, L.,
2002. Beta cells are responsible for CXCR3-mediated T-cell infiltration in
insulitis. Nat. Med. 8 (12), 1414–1420.
Fujinami, R.S., von Herrath, M.G., Christen, U., Whitton, J.L., 2006. Molecular
mimicry, bystander activation, or viral persistence: infections and auto-
immune disease. Clin. Microbiol. Rev. 19 (1), 80–94.
Garcia-Sastre, A., Biron, C.A., 2006. Type 1 interferons and the virus–host
relationship: a lesson in detente. Science 312 (5775), 879–882.
Gillespie, K.M., 2006. Type 1 diabetes: pathogenesis and prevention. Cmaj 175
(2), 165–170.
Gitlin, L., Barchet, W., Gilfillan, S., Cella, M., Beutler, B., Flavell, R.A.,
Diamond, M.S., Colonna, M., 2006. Essential role of MDA-5 in type I
IFN responses to polyriboinosinic:polyribocytidylic acid and encepha-lomyocarditis picornavirus. Proc. Natl. Acad. Sci. U.S.A. 103 (22),
8459–8464.
Goto, M., Eich, T.M., Felldin, M., Foss, A., Kallen, R., Salmela, K., Tibell, A.,
Tufveson, G., Fujimori, K., Engkvist, M., Korsgren, O., 2004. Refinement
of the automated method for human islet isolation and presentation of a
closed system for in vitro islet culture. Transplantation 78 (9), 1367–1375.
Helbig, K.J., Lau, D.T., Semendric, L., Harley, H.A., Beard, M.R., 2005.
Analysis of ISG expression in chronic hepatitis C identifies viperin as a
potential antiviral effector. Hepatology 42 (3), 702–710.
Hill, N.J., Hultcrantz, M., Sarvetnick, N., Flodstrom-Tullberg, M., 2007. The
target tissue in autoimmunity—An influential niche. Eur. J. Immunol. 37
(3), 589–597.
Hindersson, M., Elshebani, A., Orn, A., Tuvemo, T., Frisk, G., 2005.
Simultaneous type 1 diabetes onset in mother and son coincident with an
enteroviral infection. J. Clin. Virol. 33 (2), 158–167.
Hornung, V., Ellegast, J., Kim, S., Brzozka, K., Jung, A., Kato, H., Poeck, H.,
Akira, S., Conzelmann, K.K., Schlee, M., Endres, S., Hartmann, G., 2006.
5′-Triphosphate RNA is the ligand for RIG-I. Science 314 (5801), 994–997.
Horwitz, M.S., Bradley, L.M., Harbertson, J., Krahl, T., Lee, J., Sarvetnick, N.,
1998. Diabetes induced by Coxsackie virus: initiation by bystander damage
and not molecular mimicry. Nat. Med. 4 (7), 781–785.
Horwitz, M.S., Fine, C., Ilic, A., Sarvetnick, N., 2001. Requirements for viral-
mediated autoimmune diabetes: beta-cell damage and immune infiltration.
J. Autoimmun. 16 (3), 211–217.
Horwitz, M.S., Ilic, A., Fine, C., Rodriguez, E., Sarvetnick, N., 2002. Presented
antigen from damaged pancreatic beta cells activates autoreactive T cells in
virus-mediated autoimmune diabetes. J. Clin. Invest. 109 (1), 79–87.
Hyoty, H., Taylor, K.W., 2002. The role of viruses in human diabetes.
Diabetologia 45 (10), 1353–1361.
Hyoty, H., Hiltunen, M., Knip, M., Laakkonen, M., Vahasalo, P., Karjalainen, J.,
Koskela, P., Roivainen, M., Leinikki, P., Hovi, T., et al., 1995. A prospective
study of the role of coxsackie B and other enterovirus infections in the
pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study
Group. Diabetes 44 (6), 652–657.
Johansson, U., Olsson, A., Gabrielsson, S., Nilsson, B., Korsgren, O., 2003.
Inflammatory mediators expressed in human islets of Langerhans:
implications for islet transplantation. Biochem. Biophys. Res. Commun.
308 (3), 474–479.
Justesen, J., Hartmann, R., Kjeldgaard, N.O., 2000. Gene structure and function
of the 2′–5′-oligoadenylate synthetase family. Cell. Mol. Life Sci. 57 (11),
1593–1612.
Kang, D.C., Gopalkrishnan, R.V., Lin, L., Randolph, A., Valerie, K., Pestka, S.,
Fisher, P.B., 2004. Expression analysis and genomic characterization of
human melanoma differentiation associated gene-5, MDA-5: a novel type I
interferon-responsive apoptosis-inducing gene. Oncogene 23 (9), 1789–1800.
Kanno, T., Kim, K., Kono, K., Drescher, K.M., Chapman, N.M., Tracy, S., 2006.
Group B coxsackievirus diabetogenic phenotype correlates with replication
efficiency. J. Virol. 80 (11), 5637–5643.
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K.,
Uematsu, S., Jung, A., Kawai, T., Ishii, K.J., Yamaguchi, O., Otsu, K.,
Tsujimura, T., Koh, C.S., Reis e Sousa, C., Matsuura, Y., Fujita, T., Akira, S.,
2006. Differential roles of MDA5 and RIG-I helicases in the recognition of
RNA viruses. Nature 441 (7089), 101–105.
Lenschow, D.J., Lai, C., Frias-Staheli, N., Giannakopoulos, N.V., Lutz, A.,
Wolff, T., Osiak, A., Levine, B., Schmidt, R.E., Garcia-Sastre, A., Leib,
D.A., Pekosz, A., Knobeloch, K.P., Horak, I., Virgin, H.W.t., 2007. From
the cover: IFN-stimulated gene 15 functions as a critical antiviral mole-
cule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci.
U.S.A. 104 (4), 1371–1376.
Malathi, K., Paranjape, J.M., Bulanova, E., Shim, M., Guenther-Johnson, J.M.,
Faber, P.W., Eling, T.E., Williams, B.R., Silverman, R.H., 2005. A
transcriptional signaling pathway in the IFN system mediated by 2′–5′-
oligoadenylate activation of RNase L. Proc. Natl. Acad. Sci. U.S.A. 102
(41), 14533–14538.
Mandrup-Poulsen, T., Bendtzen, K., Nielsen, J.H., Bendixen, G., Nerup, J.,
1985. Cytokines cause functional and structural damage to isolated islets of
Langerhans. Allergy 40 (6), 424–429.
Moya-Suri, V., Schlosser, M., Zimmermann, K., Rjasanowski, I., Gurtler, L.,
101M. Hultcrantz et al. / Virology 367 (2007) 92–101Mentel, R., 2005. Enterovirus RNA sequences in sera of schoolchildren in
the general population and their association with type 1-diabetes-associated
autoantibodies. J. Med. Microbiol. 54 (Pt. 9), 879–883.
Nakayama, T., Urano, T., Osano, M., Hayashi, Y., Sekine, S., Ando, T.,
Makinom, S., 1989. Outbreak of herpangina associated with Coxsackievirus
B3 infection. Pediatr. Infect. Dis. J. 8 (8), 495–498.
Olofsson, P.S., Jatta, K., Wagsater, D., Gredmark, S., Hedin, U., Paulsson-
Berne, G., Soderberg-Naucler, C., Hansson, G.K., Sirsjo, A., 2005. The
antiviral cytomegalovirus inducible gene 5/viperin is expressed in athero-
sclerosis and regulated by proinflammatory agents. Arterioscler., Thromb.,
Vasc. Biol. 25 (7), e113–e116.
Pichlmair, A., Schulz, O., Tan, C.P., Naslund, T.I., Liljestrom, P., Weber, F.,
Reis e Sousa, C., 2006. RIG-I-mediated antiviral responses to single-
stranded RNA bearing 5′-phosphates. Science 314 (5801), 997–1001.
Pozzetto, B., Gresser, I., 1985. Role of sex and early interferon production in the
susceptibility of mice to encephalomyocarditis virus. J. Gen. Virol. 66 (Pt. 4),
701–709.
Rhode, A., Pauza, M.E., Barral, A.M., Rodrigo, E., Oldstone, M.B., von
Herrath, M.G., Christen, U., 2005. Islet-specific expression of CXCL10
causes spontaneous islet infiltration and accelerates diabetes development.
J. Immunol. 175 (6), 3516–3524.
Rhodes, C.J., Taylor, K.W., 1984. Effect of human lymphoblastoid interferon on
insulin synthesis and secretion in isolated human pancreatic islets.
Diabetologia 27 (6), 601–603.
Roivainen, M., 2006. Enteroviruses: new findings on the role of enteroviruses in
type 1 diabetes. Int. J. Biochem. Cell Biol. 38 (5–6), 721–725.
Roivainen, M., Ylipaasto, P., Savolainen, C., Galama, J., Hovi, T., Otonkoski,
T., 2002. Functional impairment and killing of human beta cells by
enteroviruses: the capacity is shared by a wide range of serotypes, but the
extent is a characteristic of individual virus strains. Diabetologia 45 (5),
693–702.
Salminen, K.K., Vuorinen, T., Oikarinen, S., Helminen,M., Simell, S., Knip, M.,
Ilonen, J., Simell, O., Hyoty, H., 2004. Isolation of enterovirus strains from
children with preclinical Type 1 diabetes. Diabet. Med. 21 (2), 156–164.Sarkar, S.A., Wong, R., Hackl, S.I., Moua, O., Gill, R.G., Wiseman, A.,
Davidson, H.W., Hutton, J.C., 2007. Induction of indoleamine 2,3-
dioxygenase by interferon-gamma in human islets. Diabetes 56 (1), 72–79.
Skarsvik, S., Puranen, J., Honkanen, J., Roivainen, M., Ilonen, J., Holmberg, H.,
Ludvigsson, J., Vaarala, O., 2006. Decreased in vitro type 1 immune
response against coxsackie virus B4 in children with type 1 diabetes.
Diabetes 55 (4), 996–1003.
Smyth, D.J., Cooper, J.D., Bailey, R., Field, S., Burren, O., Smink, L.J., Guja,
C., Ionescu-Tirgoviste, C., Widmer, B., Dunger, D.B., Savage, D.A.,
Walker, N.M., Clayton, D.G., Todd, J.A., 2006. A genome-wide association
study of nonsynonymous SNPs identifies a type 1 diabetes locus in the
interferon-induced helicase (IFIH1) region. Nat. Genet. 38 (6), 617–619.
Whitton, J.L., Cornell, C.T., Feuer, R., 2005. Host and virus determinants of
picornavirus pathogenesis and tropism. Nat. Rev., Microbiol. 3 (10),
765–776.
Ylipaasto, P., Klingel, K., Lindberg, A.M., Otonkoski, T., Kandolf, R., Hovi, T.,
Roivainen, M., 2004. Enterovirus infection in human pancreatic islet cells,
islet tropism in vivo and receptor involvement in cultured islet beta cells.
Diabetologia 47 (2), 225–239.
Ylipaasto, P., Kutlu, B., Rasilainen, S., Rasschaert, J., Salmela, K., Teerijoki, H.,
Korsgren, O., Lahesmaa, R., Hovi, T., Eizirik, D.L., Otonkoski, T.,
Roivainen, M., 2005. Global profiling of coxsackievirus- and cytokine-
induced gene expression in human pancreatic islets. Diabetologia 48 (8),
1510–1522.
Yoon, J.W., Austin, M., Onodera, T., Notkins, A.L., 1979. Isolation of a virus
from the pancreas of a child with diabetic ketoacidosis. N. Engl. J. Med. 300
(21), 1173–1179.
Yoon, J.W., McClintock, P.R., Onodera, T., Notkins, A.L., 1980. Virus-induced
diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of
encephalomyocarditis virus. J. Exp. Med. 152 (4), 878–892.
Zhou, A., Paranjape, J., Brown, T.L., Nie, H., Naik, S., Dong, B., Chang, A.,
Trapp, B., Fairchild, R., Colmenares, C., Silverman, R.H., 1997. Interferon
action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-
dependent RNase L. EMBO J. 16 (21), 6355–6363.
